Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Zuprinor 10 Transdermal Patch

Prescription Icon
Prescription Required

Marketer

Sun Pharmaceutical Industries Ltd

Salt Composition

Buprenorphine (10mcg)

Overview Zuprinor 10 Transdermal Patch

Opioid-dependence and moderate-to-severe pain are effectively managed with the Zuprinor 10 Transdermal Patch, which also mitigates opioid withdrawal symptoms. Administering the patch requires precise adherence to your physician's instructions for optimal efficacy. Dosage and treatment length are individualized based on your specific needs and response. Continuous use is crucial; cessation should only occur under medical supervision. Commonly reported side effects include nausea, headache, drowsiness, dizziness, and constipation, often more pronounced initially or following dosage adjustments. These typically subside with continued use; however, persistent or severe side effects warrant patch removal and immediate medical attention. Prior to commencing treatment, inform your doctor of all pre-existing conditions and medications, as interactions are possible. Pregnant or breastfeeding individuals must seek medical counsel before using this medication.

Primary Ingredients of Zuprinor 10 Transdermal Patch

No information provided. Please provide the text you wish me to rephrase.

Uses of Zuprinor 10 Transdermal Patch

Moderate to severe pain requiring morphine, an opioid analgesic.

Major Benefits of Zuprinor 10 Transdermal Patch:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always inspect the label prior to application. Ensure the application area is clean and completely dry. Peel away the patch's protective backing. Avoid contact with the adhesive surface. Apply the patch firmly to the skin, adhesive side down, ensuring even contact.

Common Side effects of Zuprinor 10 Transdermal Patch:

  • Headache
  • Back pain
  • Drowsiness
  • Vomiting
  • Insomnia (difficulty in sleeping)
  • Dizziness
  • Abdominal pain
  • Weakness
  • Sweating
  • Constipation
  • Withdrawal syndrome
  • Infection
  • Vertigo
  • Inflammation of the nose
  • Chills
  • Flu-like symptoms
  • Nausea

How to use Zuprinor 10 Transdermal Patch:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always verify the product information before application. Apply only to clean, dry skin. Peel away the patch's protective covering, avoiding contact with the adhesive surface. Then, adhere the patch firmly to the skin, adhesive side down, ensuring even contact.

How Zuprinor 10 Transdermal Patch works:

The transdermal Zuprinor 10 Patch, a partial opioid agonist, mitigates opioid withdrawal by mimicking the effects of opioid medications. Simultaneously, it alleviates pain through interaction with specialized brain receptors, modifying the body's pain perception and response.

SAFETY ADVICE

AlcoholAlcoholNone

No drug interaction identified.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zuprinor 10 Transdermal Patches during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before using this patch.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using the Zuprinor 10 Transdermal Patch while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingNone

No drug interactions identified.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, the application of Zuprinor 10 Transdermal Patches requires careful consideration. Dosage modification of Zuprinor 10 Transdermal Patches might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe liver disease should use the Zuprinor 10 Transdermal Patch cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with significant hepatic dysfunction, an alternative pain reliever offering greater dosing flexibility may be preferable.

What if you forget to take Zuprinor 10 Transdermal Patch :

NA

Facts to Know About Zuprinor 10 Transdermal Patch

LabelValue
Chemical Type Phenanthrene Derivatives
Developing Habits .
Treatment Category Neuroscience Central Nervous System

FAQs on Zuprinor 10 Transdermal Patch

Zuprinor 10 Transdermal Patches treat severe pain inadequately managed or intolerable with other analgesics. This medication isn't for occasional or minor pain, nor is it for "as needed" pain relief. It also treats opioid use disorder.
Apply the Zuprinor 10 Transdermal Patch to clean, dry, rash-free skin with minimal hair on the upper chest, back, or arm. Use only water to clean the application site; avoid soaps, oils, or gels. Dispose of used patches safely and away from children and pets. Skin varies; follow your doctor's placement instructions.
Use only undamaged skin patches. Apply only one patch at a time, unless otherwise directed by your doctor. Avoid applying the patch to irritated or damaged skin. Keep the patch out of a child's reach. Don't let children see you apply the patch, and never refer to it as a bandage.
To prevent overdose and potential death, avoid heat sources while wearing the patch. This includes heating pads, electric blankets, tanning beds, saunas, direct sunlight, hot baths, and strenuous exercise. Heat accelerates medication absorption through the skin.
Avoid layering patches; each must adhere directly to your skin. Always consult your doctor if you have any questions about this medication.
Should you have difficulty applying the patch, avoid using bandages or tape. Consult your doctor or pharmacist.
Zuprinor 10 Transdermal Patches allow showering and swimming, but limit immersion time. Ensure the patch remains securely attached and dry the surrounding skin thoroughly afterward. If the patch becomes detached, apply a new one to a different location and return the old patch to its original packaging. Always follow your doctor's instructions.
This medication can significantly lower blood pressure, potentially causing dizziness when standing up after sitting, particularly if you're also taking anti-hypertensive drugs. Discuss this with your doctor, who may adjust your dosage.
Get immediate medical attention for shallow breathing, chest pain, rapid heart rate, seizures, lightheadedness (or feeling faint), blisters, swelling, or severe skin irritation at the patch site, nausea, vomiting, appetite loss, or liver problems such as upper abdominal pain, dark urine, pale stools, and jaundice (yellow skin or eyes).
Using Zuprinor 10 Transdermal Patches during pregnancy may lead to your baby's dependence on the medication, potentially causing serious, even life-threatening, withdrawal symptoms after birth. Newborns experiencing such withdrawal may require several weeks of medical care.
Zuprinor 10 Transdermal Patch may transfer to breast milk, potentially causing respiratory distress or life-threatening complications in infants. Consult your doctor thoroughly regarding all associated risks.
Store Zuprinor 10 Transdermal Patches at room temperature, away from heat, moisture, and sunlight, in a secure, child-resistant location. Dispose of any unused portions properly.
Zuprinor 10 Transdermal Patch, an opioid partial agonist-antagonist, provides pain relief. As a controlled substance with addictive potential, alternative pain management should be discussed with your doctor if addiction arises.
Zuprinor 10 Transdermal Patches inhibit opiate effects.
Zuprinor 10 Transdermal Patches are not associated with depression. Report any depressive symptoms to your doctor.
Zuprinor 10 Transdermal P...
994
MRP 1,150
13% off